A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome
NCT05153434
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Prader-Willi Syndrome
Interventions
DRUG:
ARD-101
Sponsor
Aardvark Therapeutics, Inc.
Collaborators
[object Object]
[object Object]